DMAAR

Drugs Made In Amer Acqutn Corp

• PUBT·22h ago

  Drugs Made in America Acquisition II posts FY25 net income of $4.2 million

• Reuters·04/08 13:03

  DRUGS MADE IN AMERICA ACQUISITION CORP SAYS DEAL ANTICIPATED TO VALUE POWER ANALYTICS GLOBAL CORP AT $1.0 BLN - SEC FILING

• Reuters·04/08 13:01

  Drugs Made In America Acquisition signs LOI to merge with Power Analytics Global at $1 billion valuation

• Reuters·04/03 20:34

  Drugs Made in America Acquisition II issues $1.4 million convertible notes financing deal

• Reuters·04/01 20:06

  Drugs Made In America Acquisition delays 10-K filing, targets April 15 submission

• Reuters·04/01 20:06

  Drugs Made in America Acquisition II delays annual report filing, targets April 15 deadline

• Reuters·03/27 20:58

  Drugs Made In America Acquisition Corp. announced an extraordinary general meeting

• Reuters·03/27 20:08

  Drugs Made In America Acquisition issued $100,000 interim convertible note to BV Advisory Partners; financing grows toward contemplated $500,000 total

• Reuters·03/17 20:02

  Drugs Made in America Acquisition II Corp. signs USD 150,000 unsecured convertible bridge note with Alpha Multi Family Office

• Reuters·03/06 22:02

  Drugs Made In America Acquisition Corp. Confirms $241.3 Million in Trust Account

• Reuters·11/18/2025 11:04

  DRUGS MADE IN AMERICA ACQUISITION CORP - ON NOV 17, APPOINTED SALEEM ELMASRI AS CHIEF FINANCIAL OFFICER - SEC FILING

• Reuters·11/18/2025 11:02

  Drugs Made In America Acquisition Corp. Appoints Saleem Elmasri as Chief Financial Officer

• Reuters·11/17/2025 11:26

  Drugs Made In America Acquisition Corp. Delays Quarterly Financial Report

• Reuters·10/01/2025 14:38

  Drugs Made In America Acquisition II LLC Reports Disposal of Common Shares of Drugs Made in America Acquisition II Corp